GSK says hepatitis B drug cured one fifth of patients in late-stage trials

Drug candidate bepirovirsen delivered a functional cure rate for 19% of patients in what the company sees as a breakthrough ...

Tune Therapeutics Presents Positive Phase 1b/2a Proof of Concept Data on TUNE-401: a First-in-Class Epigenetic Silencer for Patients with Hepatitis B at EASL 2026

Tune Therapeutics, a leading epigenome editing company, presented new data today at the European Association for the Study of Liver (EASL) Congress in Barcelona, Spain, demonstrating the first ...
Fierce Biotech

GSK’s hepatitis B drug cures one-fifth of patients in ‘major step’ for pervasive disease

After treatment with bepirovirsen, however, 19% of patients achieved the strictly defined “functional cure” criteria. For the ...
BioSpace

GSK, Ionis’ hepatitis B functional cure effectively eliminates virus in nearly 20% of patients

The antisense oligonucleotide was even more effective in patients with relatively low viral activity. More than one-quarter of these individuals had undetectable levels of the virus in the blood for ...

A potential Hepatitis B cure, Eli Lilly's vaccine bet and keeping summer anxiety in check

Researchers report that a new drug, bepirovirsen, could revolutionize hepatitis B treatment by making the virus undetectable ...